NL-OMON30850已完成不适用
A Blinded, Placebo-Controlled, Randomized, Single Ascending Dose Study in Healthy Male Subjects to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-37822681 - N/A
Johnson & Johnson Pharmaceutical0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male subjects between 18 - 55 years of age
- •BMI between 18 and 30 kg/m²
排除标准
- •History of, or currently active, significant illness or medical disorder
- •History of epilepsy or fits or unexplained black-outs
- •Significant history of or current neurological disease
研究者
相似试验
已完成
不适用
A Randomized, Blinded, Placebo-Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB033 in Healthy Adult Volunteersdemyelination10012303MSNL-OMON32724Biogen64
进行中（未招募）
1 期
Avexxin (AVX001) 3% Ointment (NG) in Atopic Dermatitis – safety and efficacy studyEUCTR2016-003013-96-DKAvexxin AS
已完成
2 期
Clinical study to evaluate the safety and efficacy of ATRICOV 452 for the treatment of COVID-19 along with the standard of care.CTRI/2021/01/030795Atrimed Pharmaceutical Pvt Ltd95
已完成
2 期
Covid Investigator Initiate Study on ProbenecidCTRI/2022/07/043726Dr Neelam Pandey75
已完成
1 期
A study to learn how safe elinzanetant is, how it affects the body, and how it moves into, through and out of the body after single and multiple doses in Japanese healthy female adultsJPRN-jRCT2071210049Myoishi Masashi62